Seth Gibbs
Amplyx Pharmaceuticals (United States)
ORCID: 0000-0003-2617-8395Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 6 papers. Top paper: “Comparative toxicokinetics of Trans-resveratrol and its major metabolites in Harlan Sprague Dawley rats and B6C3F1/N mice following oral and intravenous administration”.
Seth Gibbs, Natalie South, Jessica Pierfelice, Brian Burback, Dori R. Germolec +2 more
Seth Gibbs, Natalie South, Jeremy Smith, Esra Mutlu, Brian Burback +3 more
Jeffery Wallery, Joseph P. Novak, Seth Gibbs, Mohammed Bourdi, T. Minh‐Ha +3 more
Esra Mutlu, Seth Gibbs, Jessica Pierfelice, Jeremy Smith, Brian Burback +2 more
Vijay P. Kale, Joseph P. Novak, Seth Gibbs, T. Minh‐Ha, John C. McKew +2 more
Jill A. Harvilchuck, Seth Gibbs, Carol E. Green, Lalitha Iyer, Kathleen O’Loughlin +5 more